Prescription patterns in patients with schizophrenia in Japan: First‐quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project
Abstract Background Guideline for Pharmacological Therapy for Schizophrenia was published by the Japanese Society of Neuropsychopharmacology in 2015. "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project aimed to standardize medical practic...
Saved in:
Similar Items
-
Satisfaction with web‐based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project
by: Hitoshi Iida, et al.
Published: (2023) -
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry
by: Kazuyoshi Ogasawara, et al.
Published: (2022) -
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders
by: Kentaro Fukumoto, et al.
Published: (2023) -
Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
by: Norio Yasui‐Furukori, et al.
Published: (2022) -
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study
by: Shusuke Numata, et al.
Published: (2021)